Product References
Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer.
Cancers
Mayayo-Peralta I,Faggion B,Hoekman L,Morris B,Lieftink C,Goldsbrough I,Buluwela L,Siefert JC,Post H,Altelaar M,Beijersbergen R,Ali S,Zwart W,Prekovic S
Published figure using Estrogen Receptor alpha cocktail antibody (Product # MA5-14104) in Western Blot
Thu Dec 16 00:00:00 EST 2021
Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition.
Journal of the Royal Society, Interface
He W,Demas DM,Conde IP,Shajahan-Haq AN,Baumann WT
MA5-14104 was used in Western Blotting to show that we can add a new drug, palbociclib, to the model by measuring only two key proteins, cMyc and hyperphosphorylated RB1, and adjusting only parameters associated with the drug.
Sat Aug 01 00:00:00 EDT 2020
Tissue biomarkers in prognostication of serous ovarian cancer following neoadjuvant chemotherapy.
BioMed research international
Khandakar B,Mathur SR,Kumar L,Kumar S,Datta Gupta S,Iyer VK,Kalaivani M
MA5-14104 was used in immunohistochemistry to attempt to identify prognostic biomarkers in serous ovarian cancer patients treated with neoadjuvant chemotherapy
Mon Jan 19 00:00:00 EST 2015
Immunohistochemical study of pElk-1 expression in human breast cancer: association with breast cancer biologic profile and clinicopathologic features.
Breast (Edinburgh, Scotland)
Laliotis A,Vrekoussis T,Kafousi M,Sanidas E,Askoxilakis J,Melissas J,Mavroudis D,Castanas E,Stathopoulos EN
MA5-14104 was used in immunohistochemistry to study the role of pElk-1 in breast neoplasia
Fri Feb 01 00:00:00 EST 2013
Breast cancer tissue slices as a model for evaluation of response to rapamycin.
Cell and tissue research
Grosso SH,Katayama ML,Roela RA,Nonogaki S,Soares FA,Brentani H,Lima L,Folgueira MA,Waitzberg AF,Pasini FS,Góes JC,Brentani MM
MA5-14104 was used in immunohistochemistry to study the response to rapamycin therapy using organotypic breast cancer tissue slices and the potential utility in personalized therapy
Sat Jun 01 00:00:00 EDT 2013
Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: a report of two cases and review of literature.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Marian C,Boila A,Soanca D,Malau M,Podeanu DM,Resetkova E,Stolnicu S
MA5-14104 was used in immunohistochemistry to report on two cases of malignant transformation of adenomyoepithelioma of the breast by a monophasic population
Mon Apr 01 00:00:00 EDT 2013
Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.
Applied immunohistochemistry & molecular morphology : AIMM
Gill MS,Paish EC,Ronan J,Green AR,Ellis IO,Lee AH
MA5-14104 was used in immunohistochemistry to study the PharmDx system for the immunohistochemical detection of ER and PR in breast cancer.
Tue Jan 01 00:00:00 EST 2013
Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
Molecular cancer
Li Y,Meeran SM,Patel SN,Chen H,Hardy TM,Tollefsbol TO
MA5-14104 was used in immunohistochemistry and western blot to study the ability of genistein to epigenetically reactivate ER-alpha expression in ER-alpha-negative breast cancer and enhance tamoxifen sensitivity
Mon Feb 04 00:00:00 EST 2013
Localization and hormonal regulation of endometrial matrix metalloproteinase-26 in the rhesus macaque.
Human reproduction (Oxford, England)
Almeida-Francia CC,Keator CS,Mah K,Holden L,Hergert C,Slayden OD
MA5-14104 was used in immunohistochemistry to study the localization and regulation of endometrial MMP-26 in the rhesus macaque
Fri Jun 01 00:00:00 EDT 2012
Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation.
Breast cancer research and treatment
Chung K,Hovanessian-Larsen LJ,Hawes D,Taylor D,Downey S,Spicer DV,Stanczyk FZ,Patel S,Anderson AR,Pike MC,Wu AH,Pearce CL
MA5-14104 was used in immunohistochemistry to study the effect of short-term high endogenous estrogen exposure on human breast epithelial cell proliferation
Sun Apr 01 00:00:00 EDT 2012
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Breast cancer research and treatment
Joosse SA,Brandwijk KI,Devilee P,Wesseling J,Hogervorst FB,Verhoef S,Nederlof PM
MA5-14104 was used in immunohistochemistry to develop a method to predict BRCA2-association in hereditary breast carcinomas
Sun Apr 01 00:00:00 EDT 2012
Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.
Biology of reproduction
Machado SA,Bahr JM,Hales DB,Braundmeier AG,Quade BJ,Nowak RA
MA5-14104 was used in immunohistochemistry to validate the aging hen as a model for studying the pathophysiology of human uterine leiomyomas
Mon Oct 01 00:00:00 EDT 2012
Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.
Contraception
Hovanessian-Larsen L,Taylor D,Hawes D,Spicer DV,Press MF,Wu AH,Pike MC,Pearce CL
MA5-14104 was used in immunohistochemistry to study the expression of estrogen and progesterone receptors and the degree of breast epithelial proliferation in women taking oral contraceptives with different levels of norethindrone
Sat Sep 01 00:00:00 EDT 2012
Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
British journal of cancer
Rijlaarsdam MA,van Herk HA,Gillis AJ,Stoop H,Jenster G,Martens J,van Leenders GJ,Dinjens W,Hoogland AM,Timmermans M,Looijenga LH
MA5-14104 was used in immunohistochemistry to study OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines
Tue Sep 06 00:00:00 EDT 2011
Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.
Histopathology
Logullo AF,Stiepcich MM,Osório CA,Nonogaki S,Pasini FS,Rocha RM,Soares FA,Brentani MM
MA5-14104 was used in immunohistochemistry to study the prognostic value of Fos-related antigen 1 in ductal breast carcinoma
Tue Mar 01 00:00:00 EST 2011
Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
Genes, chromosomes & cancer
Joosse SA,Brandwijk KI,Mulder L,Wesseling J,Hannemann J,Nederlof PM
MA5-14104 was used in immunohistochemistry to study the genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors
Tue Feb 01 00:00:00 EST 2011
Differential expression pattern of estrogen receptors, aromatase, and sulfotransferase in breast cancer tissue and corresponding lymph node metastases.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Gschwantler-Kaulich D,Fink-Retter A,Czerwenka K,Hudelist G,Kaulich A,Kubista E,Singer CF
MA5-14104 was used in immunohistochemistry to study the expression of the estrogen receptor and estrogen-metabolizing enzymes in breast cancer tissue and metastases
Wed Jun 01 00:00:00 EDT 2011
The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.
Annals of oncology : official journal of the European Society for Medical Oncology
Bueno-de-Mesquita JM,Nuyten DS,Wesseling J,van Tinteren H,Linn SC,van de Vijver MJ
MA5-14104 was used in immunohistochemistry to study the significance of inter-observer variation in pathological assessment of node-negative breast cancer
Fri Jan 01 00:00:00 EST 2010
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research
Horlings HM,Lai C,Nuyten DS,Halfwerk H,Kristel P,van Beers E,Joosse SA,Klijn C,Nederlof PM,Reinders MJ,Wessels LF,van de Vijver MJ
MA5-14104 was used in immunohistochemistry to study the implication of DNA copy number in the prognostic markers for breast cancer patients
Fri Jan 15 00:00:00 EST 2010
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers.
BMC cancer
Holstege H,van Beers E,Velds A,Liu X,Joosse SA,Klarenbeek S,Schut E,Kerkhoven R,Klijn CN,Wessels LF,Nederlof PM,Jonkers J
MA5-14104 was used in immunohistochemistry to evaluate array comparative genomic hybridization data from murine and human BRCA1 and BRCA2 breast cancers
Tue Aug 24 00:00:00 EDT 2010
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
Breast cancer research and treatment
Joosse SA,van Beers EH,Tielen IH,Horlings H,Peterse JL,Hoogerbrugge N,Ligtenberg MJ,Wessels LF,Axwijk P,Verhoef S,Hogervorst FB,Nederlof PM
MA5-14104 was used in immunohistochemistry to study the role of BRCA1 in hereditary non-BRCA1/2 breast carcinomas
Sat Aug 01 00:00:00 EDT 2009
HER-2/neu (c-erbB-2) oncoprotein in hyperplastic endometrial polyps detected in two cats.
Journal of feline medicine and surgery
Misirlioglu D,Nak D,Ozyigit MO,Nak Y,Akkoc A
MA5-14104 was used in immunohistochemistry to study the HER-2/neu (c-erbB-2) oncoprotein in hyperplastic endometrial polyps detected in two cats
Thu Oct 01 00:00:00 EDT 2009
EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.
Breast cancer research : BCR
Pietersen AM,Horlings HM,Hauptmann M,Langerød A,Ajouaou A,Cornelissen-Steijger P,Wessels LF,Jonkers J,van de Vijver MJ,van Lohuizen M
MA5-14104 was used in immunohistochemistry to study the prognostic value of EZH2 and BMI1 overexpression in breast cancer
Tue Apr 07 00:00:00 EDT 2009
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients.
Anti-cancer drugs
Bao H,Yu D,Wang J,Qiu T,Yang J,Wang L
MA5-14104 was used in immunohistochemistry to investigate the prognostic markers of taxane-based and anthracycline-based neoadjuvant chemotherapy for breast carcinoma
Sat Mar 01 00:00:00 EST 2008
Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern.
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
Ceauşu M,Terzea D,Georgescu A,Dobrea C,Mihai M,Iosif C,Vasilescu F,Ardeleanu C
MA5-14104 was used in immunohistochemistry to study the histological and immunological characteristics of transitional cell tumors of the ovary
Wed Sep 30 00:00:00 EDT 2009
Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
Applied immunohistochemistry & molecular morphology : AIMM
Chakravarty D,Srinivasan R,Ghosh S,Rajwanshi A,Gopalan S
MA5-14104 was used in immunohistochemistry to study the expression of estrogen receptor beta in endometrial simple hyperplasia and endometrioid carcinoma
Mon Dec 01 00:00:00 EST 2008
Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Schmidt MK,Tollenaar RA,de Kemp SR,Broeks A,Cornelisse CJ,Smit VT,Peterse JL,van Leeuwen FE,Van't Veer LJ
MA5-14104 was used in immunohistochemistry to study breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation
Mon Jan 01 00:00:00 EST 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
Cancer cell
Berns K,Horlings HM,Hennessy BT,Madiredjo M,Hijmans EM,Beelen K,Linn SC,Gonzalez-Angulo AM,Stemke-Hale K,Hauptmann M,Beijersbergen RL,Mills GB,van de Vijver MJ,Bernards R
MA5-14104 was used in immunohistochemistry to investigate the mechanism for breast tumor resistance to trastuzumab
Mon Oct 01 00:00:00 EDT 2007
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research
Barbareschi M,Buttitta F,Felicioni L,Cotrupi S,Barassi F,Del Grammastro M,Ferro A,Dalla Palma P,Galligioni E,Marchetti A
MA5-14104 was used in immunohistochemistry to study the prognostic value of different PIK3CA gene mutations in breast cancer
Mon Oct 15 00:00:00 EDT 2007
The effect of maturation and age on oestrogen-induced functional hypertrophy of the female rabbit bladder.
BJU international
Onal B,Levin RM,Kogan BA,Whitbeck C,Chichester P,Walebowa O,Mannikarottu AS
MA5-14104 was used in immunohistochemistry to study the effect of maturation and ageing on oestrogen-induced functional hypertrophy of the female rabbit bladder
Thu Mar 01 00:00:00 EST 2007
Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Wang M,Pan JY,Song GR,Chen HB,An LJ,Qu SX
MA5-14104 was used in immunohistochemistry to study the altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma
Thu Mar 01 00:00:00 EST 2007
Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy.
British journal of cancer
Hannemann J,Kristel P,van Tinteren H,Bontenbal M,van Hoesel QG,Smit WM,Nooij MA,Voest EE,van der Wall E,Hupperets P,de Vries EG,Rodenhuis S,van de Vijver MJ
MA5-14104 was used in immunohistochemistry to study molecular subtypes of breast cancer and amplification of topoisomerase II alpha
Mon Nov 20 00:00:00 EST 2006
PAK1 hyperactivation is sufficient for mammary gland tumor formation.
Oncogene
Wang RA,Zhang H,Balasenthil S,Medina D,Kumar R
MA5-14104 was used in immunohistochemistry to study the role of PAK1 hyperactivation in mammary gland tumor formation
Thu May 11 00:00:00 EDT 2006
Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
Endocrine-related cancer
Singer CF,Fink-Retter A,Gschwantler-Kaulich D,Thalhammer T,Hudelist G,Mueller R,Czerwenka K,Kubista E
MA5-14104 was used in immunohistochemistry to study the immunohistochemical expression of aromatase and sulfotransferase in breast cancer tissue and the significance for local estrogen levels
Fri Dec 01 00:00:00 EST 2006
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
Journal of natural products
Turbyville TJ,Wijeratne EM,Liu MX,Burns AM,Seliga CJ,Luevano LA,David CL,Faeth SH,Whitesell L,Gunatilaka AA
MA5-14104 was used in western blot to isolate and characterize compounds from plant-associated fungi with potential Hsp90-mediated anticancer activity
Wed Feb 01 00:00:00 EST 2006
Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
Gynecologic and obstetric investigation
Inceboz US,Nese N,Uyar Y,Ozcakir HT,Kurtul O,Baytur YB,Kandiloglu AR,Caglar H,Fraser IS
MA5-14104 was used in immunohistochemistry to study the expression of hormone receptors and proliferative markers in postmenopausal endometrial polyps
Tue Jan 30 00:00:00 EST 2007
Estrogen induced functional hypertrophy and increased force generation of the female rabbit bladder.
Neurourology and urodynamics
Lin AD,Levin R,Kogan B,Whitbeck C,Chichester P,Sokol R,Mannikarottu A
MA5-14104 was used in immunohistochemistry to examine the effect of estrogen in female rabbit bladder
Tue Oct 10 00:00:00 EDT 2006
The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Gynecologic oncology
Akhan SE,Yavuz E,Tecer A,Iyibozkurt CA,Topuz S,Tuzlali S,Bengisu E,Berkman S
MA5-14104 was used in immunohistochemistry to study the role of Ki-67, p53, estrogen and progesterone receptors in uterine leiomyosarcomas
Sat Oct 01 00:00:00 EDT 2005
Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Carcinogenesis
Qiu C,Shan L,Yu M,Snyderwine EG
MA5-14104 was used in immunohistochemistry to investigate the effect of 2-amino-1-methyl-6-phenylimidazo[4,5-beta]pyridine on the rat mammary gland carcinomas
Fri Apr 01 00:00:00 EST 2005
The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters.
Breast cancer research and treatment
Gao RJ,Bao HZ,Yang Q,Cong Q,Song JN,Wang L
MA5-14104 was used in immunohistochemistry to investigate the presence and utility of p53 antibodies in patients with breast cancer
Thu Sep 01 00:00:00 EDT 2005
The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Cancer
Guler G,Uner A,Guler N,Han SY,Iliopoulos D,Hauck WW,McCue P,Huebner K
MA5-14104 was used in immunohistochemistry to study the coordinate inactivation of the fragile genes FHIT and WWOX in invasive breast carcinoma
Thu Apr 15 00:00:00 EDT 2004
Molecular mechanism of estrogen receptor (ER)alpha-specific, estradiol-dependent expression of the progesterone receptor (PR) B-isoform.
The Journal of steroid biochemistry and molecular biology
Flötotto T,Niederacher D,Hohmann D,Heimerzheim T,Dall P,Djahansouzi S,Bender HG,Hanstein B
MA5-14104 was used in western blot to study estrogen receptor alpha-dependent upregulation of progesterone receptor-B expression by estradiol
Sun Feb 01 00:00:00 EST 2004
Expression of CYP3A4 in human breast tumour and non-tumour tissues.
Cancer letters
Kapucuoglu N,Coban T,Raunio H,Pelkonen O,Edwards RJ,Boobis AR,Iscan M
MA5-14104 was used in immunocytochemistry to study the expression of CYP3A4 protein in breast tumour and non-tumour tissues
Mon Dec 08 00:00:00 EST 2003
Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
Breast cancer research and treatment
Hudelist G,Czerwenka K,Kubista E,Marton E,Pischinger K,Singer CF
MA5-14104 was used in immunohistochemistry to study the expression of estrogen receptors and their transcriptional co-factors in normal and malignant breast tissue
Sat Mar 01 00:00:00 EST 2003
Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Molecular and cellular endocrinology
Zinser GM,McEleney K,Welsh J
MA5-14104 was used in western blot to characterize mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice
Fri Feb 28 00:00:00 EST 2003
Cellular and molecular targets of estrogen in normal human breast tissue.
Cancer research
Seth P,Porter D,Lahti-Domenici J,Geng Y,Richardson A,Polyak K
MA5-14104 was used in western blot to study genes involved in estrogen signaling in human breast tissue
Thu Aug 15 00:00:00 EDT 2002
5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
The Journal of clinical endocrinology and metabolism
Suzuki T,Darnel AD,Akahira JI,Ariga N,Ogawa S,Kaneko C,Takeyama J,Moriya T,Sasano H
MA5-14104 was used in immunohistochemistry and western blot to study the role of 5alpha-reductases in human breast carcinoma
Tue May 01 00:00:00 EDT 2001
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.
Breast cancer research and treatment
Querzoli P,Albonico G,di Iasio MG,Ferretti S,Rinaldi R,Cariello A,Pedriali M,Matteuzzi M,Maestri I,Nenci I
MA5-14104 was used in immunohistochemistry to study the effects of loss of heterozygosity of BRCA1 and TP53 on breast cancer survival in young women
Thu Mar 01 00:00:00 EST 2001
Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells.
Steroids
El Khissiin A,Journé F,Laïos I,Seo HS,Leclercq G
MA5-14104 was used in immunocytochemistry to study an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells
Fri Dec 01 00:00:00 EST 2000